{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:52:10Z","timestamp":1792511530295,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01163-4","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:40:56Z","timestamp":1748364056000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A VLPs based vaccine protects against Zika virus infection and prevents cerebral and testicular damage"],"prefix":"10.1038","volume":"10","author":[{"given":"Nelson","family":"C\u00f4rtes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline D. Q.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasim A.","family":"Prates-Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Dur\u00e3es-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Balan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels O. S.","family":"C\u00e2mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio","family":"Cabral-Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester C.","family":"Sabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 E.","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Cabral-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"1163_CR1","first-page":"345","volume":"352","author":"NR Faria","year":"2016","unstructured":"Faria, N. R., et al. Zika virus in the Americas: early epidemiological and genetic findings. Science (1979). 352, 345\u2013349 (2016).","journal-title":"Science (1979)."},{"key":"1163_CR2","doi-asserted-by":"crossref","unstructured":"Song, B. H., Yun, S. I., Woolley, M. & Lee, Y. M. Zika virus: history, epidemiology, transmission, and clinical presentation. J. Neuroimmunol. 308, 50\u201364 (2017).","DOI":"10.1016\/j.jneuroim.2017.03.001"},{"key":"1163_CR3","doi-asserted-by":"crossref","unstructured":"Pielnaa, P. et al. Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development. Virology 543, 34\u201342 (2020).","DOI":"10.1016\/j.virol.2020.01.015"},{"key":"1163_CR4","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3389\/fmicb.2016.01667","volume":"7","author":"\u00c1 Fajardo","year":"2016","unstructured":"Fajardo, \u00c1, Cristina, J. & Moreno, P. Emergence and spreading potential of Zika virus. Front. Microbiol.7, 1667 (2016).","journal-title":"Front. Microbiol."},{"key":"1163_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.antiviral.2016.03.010","volume":"130","author":"SC Weaver","year":"2016","unstructured":"Weaver, S. C., et al. Zika virus: history, emergence, biology, and prospects for control. Antivir. Res. 130, 69\u201380 (2016).","journal-title":"Antivir. Res."},{"key":"1163_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0140-6736(17)31368-5","volume":"390","author":"WK de Oliveira","year":"2017","unstructured":"de Oliveira, W. K., et al. Infection-related microcephaly after the 2015 and 2016 Zika virus outbreaks in Brazil: a surveillance-based analysis. Lancet 390, 861\u2013870 (2017).","journal-title":"Lancet"},{"key":"1163_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.virol.2022.07.004","volume":"574","author":"N Akhtar","year":"2022","unstructured":"Akhtar, N., Gupta, S. K. & Singh, H. Surveillance of Zika and Dengue viruses in field-collected Aedes aegypti mosquitoes from different states of India. Virology 574, 96\u2013101 (2022).","journal-title":"Virology"},{"key":"1163_CR8","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ijid.2022.07.017","volume":"122","author":"JA Cardona-Ospina","year":"2022","unstructured":"Cardona-Ospina, J. A., et al. Susceptibility to endemic Aedes-borne viruses among pregnant women in Risaralda, Colombia. Int. J. Infect. Dis. 122, 832\u2013840 (2022).","journal-title":"Int. J. Infect. Dis."},{"key":"1163_CR9","unstructured":"PAHO\/WHO. Actualizaci\u00f3n Epidemiol\u00f3gica: Dengue y otras Arbovirosis 1\u201315 (Pan American Health Organization, Washington, DC, USA, 2020)."},{"key":"1163_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.tmaid.2018.10.022","volume":"27","author":"SK Saxena","year":"2019","unstructured":"Saxena, S. K. et al. Zika virus disease in India - Update October 2018. Travel Med. Infect. Dis. 27, 121\u2013122 (2019).","journal-title":"Travel Med. Infect. Dis."},{"key":"1163_CR11","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1002\/jmv.27638","volume":"94","author":"PD Yadav","year":"2022","unstructured":"Yadav, P. D., et al. Detection of Zika virus disease in Thiruvananthapuram, Kerala, India 2021 during the second wave of COVID-19 pandemic. J. Med. Virol. 94, 2346\u20132349 (2022).","journal-title":"J. Med. Virol."},{"key":"1163_CR12","doi-asserted-by":"publisher","first-page":"e2150","DOI":"10.1002\/rmv.2105","volume":"30","author":"FA Jorge","year":"2020","unstructured":"Jorge, F. A. et al. Evolutions and upcoming on Zika virus diagnosis through an outbreak: a systematic review. Rev. Med. Virol. 30, e2150 (2020).","journal-title":"Rev. Med. Virol."},{"key":"1163_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","volume":"15","author":"S Lee","year":"2015","unstructured":"Lee, S. & Nguyen, M. T. Recent advances of vaccine adjuvants for infectious diseases. Immune Netw. 15, 51 (2015).","journal-title":"Immune Netw."},{"key":"1163_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2022.114302","volume":"210","author":"DC Albuquerque","year":"2022","unstructured":"Albuquerque, D. C., et al. Combined detection of molecular and serological signatures of viral infections: the dual assay concept. Biosens. Bioelectron. 210, 114302 (2022).","journal-title":"Biosens. Bioelectron."},{"key":"1163_CR15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/pd.5446","volume":"39","author":"L Pomar","year":"2019","unstructured":"Pomar, L., et al. Zika virus during pregnancy: from maternal exposure to congenital Zika virus syndrome. Prenat. Diagn. 39, 420\u2013430 (2019).","journal-title":"Prenat. Diagn."},{"key":"1163_CR16","doi-asserted-by":"crossref","unstructured":"Ferraris, P., Yssel, H. & Miss\u00e9, D. Zika virus infection: an update. Microbes Infect. 21, 353\u2013360 (2019).","DOI":"10.1016\/j.micinf.2019.04.005"},{"key":"1163_CR17","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/S0140-6736(17)31450-2","volume":"390","author":"D Baud","year":"2017","unstructured":"Baud, D., Gubler, D. J., Schaub, B., Lanteri, M. C. & Musso, D. An update on Zika virus infection. Lancet 390, 2099\u20132109 (2017).","journal-title":"Lancet"},{"key":"1163_CR18","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S0140-6736(16)30883-2","volume":"388","author":"RB Martines","year":"2016","unstructured":"Martines, R. B., et al. Pathology of congenital Zika syndrome in Brazil: a case series. Lancet 388, 898\u2013904 (2016).","journal-title":"Lancet"},{"key":"1163_CR19","doi-asserted-by":"publisher","first-page":"e0011270","DOI":"10.1371\/journal.pntd.0011270","volume":"17","author":"C Braga","year":"2023","unstructured":"Braga, C., et al. Seroprevalence of Dengue, Chikungunya and Zika at the epicenter of the congenital microcephaly epidemic in Northeast Brazil: a population-based survey. PLoS Negl. Trop. Dis. 17, e0011270 (2023).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1163_CR20","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1056\/NEJMc1800098","volume":"379","author":"ME Lopes Moreira","year":"2018","unstructured":"Lopes Moreira, M. E., et al. Neurodevelopment in infants exposed to Zika virus In utero. N. Engl. J. Med. 379, 2377\u20132379 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1163_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMp1605367","volume":"375","author":"MA Johansson","year":"2016","unstructured":"Johansson, M. A., Mier-y-Teran-Romero, L., Reefhuis, J., Gilboa, S. M. & Hills, S. L. Zika and the risk of microcephaly. N. Engl. J. Med. 375, 1\u20134 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1163_CR22","doi-asserted-by":"publisher","first-page":"1281667","DOI":"10.3389\/fimmu.2023.1281667","volume":"14","author":"N C\u00f4rtes","year":"2023","unstructured":"C\u00f4rtes, N. et al. Integrated control strategies for dengue, Zika, and Chikungunya virus infections. Front. Immunol. 14, 1281667 (2023).","journal-title":"Front. Immunol."},{"key":"1163_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S1473-3099(17)30727-2","volume":"18","author":"TVB de Ara\u00fajo","year":"2018","unstructured":"de Ara\u00fajo, T. V. B., et al. Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report of a case-control study. Lancet Infect. Dis. 18, 328\u2013336 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"1163_CR24","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3201\/eid2205.160107","volume":"22","author":"B Atkinson","year":"2016","unstructured":"Atkinson, B., et al. Detection of Zika virus in semen. Emerg. Infect. Dis. 22, 940\u2013940 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"1163_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38223-z","volume":"14","author":"W Yang","year":"2023","unstructured":"Yang, W., et al. Single-cell RNA sequencing reveals the fragility of male spermatogenic cells to Zika virus-induced complement activation. Nat. Commun. 14, 2476 (2023).","journal-title":"Nat. Commun."},{"key":"1163_CR26","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1016\/j.celrep.2016.11.070","volume":"17","author":"WW Tang","year":"2016","unstructured":"Tang, W. W., et al. A mouse model of Zika virus sexual transmission and vaginal viral replication. Cell Rep. 17, 3091\u20133098 (2016).","journal-title":"Cell Rep."},{"key":"1163_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1473-3099(16)00138-9","volume":"16","author":"JM Mansuy","year":"2016","unstructured":"Mansuy, J. M., et al. Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen? Lancet Infect. Dis. 16, 405 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"1163_CR28","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1099\/0022-1317-82-8-1867","volume":"82","author":"MW Gaunt","year":"2001","unstructured":"Gaunt, M. W. et al. Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography. J. Gen. Virol. 82, 1867\u20131876 (2001).","journal-title":"J. Gen. Virol."},{"key":"1163_CR29","doi-asserted-by":"publisher","first-page":"e01123","DOI":"10.1128\/mBio.01123-16","volume":"7","author":"JA Swanstrom","year":"2016","unstructured":"Swanstrom, J. A. et al. Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus. mBio 7, e01123\u201316 (2016).","journal-title":"mBio"},{"key":"1163_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature18938","volume":"536","author":"G Barba-Spaeth","year":"2016","unstructured":"Barba-Spaeth, G., et al. Structural basis of potent Zika\u2013dengue virus antibody cross-neutralization. Nature 536, 48\u201353 (2016).","journal-title":"Nature"},{"key":"1163_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aal4365","volume":"356","author":"SV Bardina","year":"2017","unstructured":"Bardina, S. V., et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 356, 175\u2013180 (2017).","journal-title":"Science"},{"key":"1163_CR32","doi-asserted-by":"publisher","first-page":"7852","DOI":"10.1073\/pnas.1607931113","volume":"113","author":"L Priyamvada","year":"2016","unstructured":"Priyamvada, L., et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc. Natl Acad. Sci. USA 113, 7852\u20137857 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1163_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12250-019-00093-5","volume":"34","author":"C Yang","year":"2019","unstructured":"Yang, C., Gong, R. & de Val, N. Development of neutralizing antibodies against zika virus based on its envelope protein structure. Virol. Sin. 34, 168\u2013174 (2019).","journal-title":"Virol. Sin."},{"key":"1163_CR34","doi-asserted-by":"crossref","unstructured":"Liang, H. et al. Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice. PLoS ONE 13, https:\/\/pubmed.ncbi.nlm.nih.gov\/29590178\/ (2018)","DOI":"10.1371\/journal.pone.0194860"},{"key":"1163_CR35","doi-asserted-by":"crossref","unstructured":"Conlan, S. et al. Role of Zika virus envelope protein domain iii as a target of human neutralizing antibodies. mBio 10, https:\/\/pubmed.ncbi.nlm.nih.gov\/31530669\/ (2019)","DOI":"10.1128\/mBio.01485-19"},{"key":"1163_CR36","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1016\/j.vaccine.2017.04.052","volume":"35","author":"M Yang","year":"2017","unstructured":"Yang, M., Dent, M., Lai, H., Sun, H. & Chen, Q. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus. Vaccine 35, 4287\u20134294 (2017).","journal-title":"Vaccine"},{"key":"1163_CR37","doi-asserted-by":"crossref","unstructured":"P\u00e9rez, O. et al. Adjuvants are key factors for the development of future vaccines: lessons from the Finlay adjuvant platform. Front. Immunol. 4, 407 (2013).","DOI":"10.3389\/fimmu.2013.00407"},{"key":"1163_CR38","doi-asserted-by":"crossref","unstructured":"Cabral-Miranda, G. et al. Zika virus-derived E-DIII protein displayed on immunologically optimized VLPs induces neutralizing antibodies without causing enhancement of Dengue virus infection. Vaccines (Basel) 7, 72 (2019).","DOI":"10.3390\/vaccines7030072"},{"key":"1163_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-76163-w","volume":"14","author":"L Vuitika","year":"2024","unstructured":"Vuitika, L., et al. A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective. Sci. Rep. 14, 24228 (2024).","journal-title":"Sci. Rep."},{"key":"1163_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0378-1119(93)90261-Z","volume":"137","author":"TM Kozlovska","year":"1993","unstructured":"Kozlovska, T. M., et al. Recombinant RNA phage q\u03b2 capsid particles synthesized and self-assembled in Escherichia coli. Gene 137, 133\u2013137 (1993).","journal-title":"Gene"},{"key":"1163_CR41","doi-asserted-by":"publisher","first-page":"11155","DOI":"10.1021\/bi901306p","volume":"48","author":"SD Brown","year":"2009","unstructured":"Brown, S. D., Fiedler, J. D. & Finn, M. G. Assembly of hybrid bacteriophage Q\u03b2 virus-like particles NIH Public Access. Biochemistry 48, 11155\u201311157 (2009).","journal-title":"Biochemistry"},{"key":"1163_CR42","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1099\/vir.0.19443-0","volume":"84","author":"K Tegerstedt","year":"2003","unstructured":"Tegerstedt, K., et al. Murine pneumotropic virus VP1 virus-like particles (VLPs) bind to several cell types independent of sialic acid residues and do not serologically cross react with murine polyomavirus VP1 VLPs. J. Gen. Virol. 84, 3443\u20133452 (2003).","journal-title":"J. Gen. Virol."},{"key":"1163_CR43","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3389\/fimmu.2019.01679","volume":"10","author":"AC Gomes","year":"2019","unstructured":"Gomes, A. C. et al. Early transcriptional signature in dendritic cells and the induction of protective t cell responses upon immunization with VLPs containing TLR ligands\u2014a role for CCL2. Front. Immunol. 10, 1679 (2019).","journal-title":"Front. Immunol."},{"key":"1163_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/jps.22267","volume":"100","author":"LA Brito","year":"2011","unstructured":"Brito, L. A. & Singh, M. Acceptable levels of endotoxin in vaccine formulations during preclinical research. J. Pharm. Sci. 100, 34\u201337 (2011).","journal-title":"J. Pharm. Sci."},{"key":"1163_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bios.2018.04.058","volume":"113","author":"G Cabral-Miranda","year":"2018","unstructured":"Cabral-Miranda, G., Cardoso, A. R., Ferreira, L. C. S., Sales, M. G. F. & Bachmann, M. F. Biosensor-based selective detection of Zika virus specific antibodies in infected individuals. Biosens. Bioelectron. 113, 101\u2013107 (2018).","journal-title":"Biosens. Bioelectron."},{"key":"1163_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/vaccines5020010","volume":"5","author":"G Cabral-Miranda","year":"2017","unstructured":"Cabral-Miranda, G., et al. Virus-like particle (VLP) plus microcrystalline tyrosine (MCT) adjuvants enhance vaccine efficacy improving t and b cell immunogenicity and protection against Plasmodium berghei\/vivax. Vaccines (Basel) 5, 10 (2017).","journal-title":"Vaccines (Basel)"},{"key":"1163_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/diseases6040107","volume":"6","author":"G Cabral-Miranda","year":"2018","unstructured":"Cabral-Miranda, G., et al. DOPS adjuvant confers enhanced protection against malaria for VLP-TRAP based vaccines. Diseases 6, 107 (2018).","journal-title":"Diseases"},{"key":"1163_CR48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/vaccines5040032","volume":"5","author":"G Cabral-Miranda","year":"2017","unstructured":"Cabral-Miranda, G., et al. Microcrystalline tyrosine (MCT\u00ae): a depot adjuvant in licensed allergy immunotherapy offers new opportunities in malaria. Vaccines (Basel) 5, 32 (2017).","journal-title":"Vaccines (Basel)"},{"key":"1163_CR49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/vaccines8010116","volume":"8","author":"ES Roesti","year":"2020","unstructured":"Roesti, E. S., et al. Vaccination against amyloidogenic aggregates in pancreatic islets prevents development of type 2 diabetes mellitus. Vaccines (Basel) 8, 116 (2020).","journal-title":"Vaccines (Basel)"},{"key":"1163_CR50","doi-asserted-by":"publisher","first-page":"e0005704","DOI":"10.1371\/journal.pntd.0005704","volume":"11","author":"SD Dowall","year":"2017","unstructured":"Dowall, S. D., et al. Lineage-dependent differences in the disease progression of Zika virus infection in type-I interferon receptor knockout (A129) mice. PLoS Negl. Trop. Dis. 11, e0005704 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1163_CR51","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","volume":"19","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M., et al. A mouse model of Zika virus pathogenesis. Cell Host Microbe 19, 720\u2013730 (2016).","journal-title":"Cell Host Microbe"},{"key":"1163_CR52","doi-asserted-by":"crossref","unstructured":"Clancy, C. S., Van Wettere, A. J., Siddharthan, V., Morrey, J. D. & Julander, J. G. Comparative histopathologic lesions of the male reproductive tract during acute infection of Zika virus in AG129 and Ifnar \u00c0\/\u00c0 mice. Am. J. Pathol. 188, 904\u2013915 (2018).","DOI":"10.1016\/j.ajpath.2017.12.019"},{"key":"1163_CR53","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41467-017-00737-8","volume":"8","author":"C Shan","year":"2017","unstructured":"Shan, C. et al. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat. Commun. 8, 676 (2017).","journal-title":"Nat. Commun."},{"key":"1163_CR54","doi-asserted-by":"publisher","unstructured":"Let\u00edcia, M. et al. Early infection of Zika virus in the male reproductive system of AG129 mice: molecular and immunohistochemical evaluation. Clin. Microbiol. 53, https:\/\/doi.org\/10.1007\/s42770-022-00761-x (2022).","DOI":"10.1007\/s42770-022-00761-x"},{"key":"1163_CR55","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.stem.2016.08.005","volume":"19","author":"H Li","year":"2016","unstructured":"Li, H., et al. Zika Virus infects neural progenitors in the adult mouse brain and alters proliferation. Cell Stem Cell 19, 593\u2013598 (2016).","journal-title":"Cell Stem Cell"},{"key":"1163_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11866-7","volume":"10","author":"CP Figueiredo","year":"2019","unstructured":"Figueiredo, C. P., et al. Zika virus replicates in adult human brain tissue and impairs synapses and memory in mice. Nat. Commun. 10, 3890 (2019).","journal-title":"Nat. Commun."},{"key":"1163_CR57","doi-asserted-by":"crossref","unstructured":"Aliota, M. T. et al. Characterization of Lethal Zika Virus Infection in AG129 Mice. PLoS Negl. Trop. Dis. 10, e0004682 (2016).","DOI":"10.1371\/journal.pntd.0004682"},{"key":"1163_CR58","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nm.4322","volume":"23","author":"C Shan","year":"2017","unstructured":"Shan, C., et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat. Med. 23, 763\u2013767 (2017).","journal-title":"Nat. Med."},{"key":"1163_CR59","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1473-3099(20)30085-2","volume":"20","author":"KE Stephenson","year":"2020","unstructured":"Stephenson, K. E., et al. Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial. Lancet Infect. Dis. 20, 1061\u20131070 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"1163_CR60","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/21645515.2014.1004026","volume":"11","author":"P He","year":"2015","unstructured":"He, P., Zou, Y. & Hu, Z. Advances in aluminum hydroxide-based adjuvant research and its mechanism. Hum. Vaccin Immunother. 11, 477\u2013488 (2015).","journal-title":"Hum. Vaccin Immunother."},{"key":"1163_CR61","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/eji.201747150","volume":"48","author":"E Oleszycka","year":"2018","unstructured":"Oleszycka, E., et al. The vaccine adjuvant alum promotes IL-10 production that suppresses Th1 responses. Eur. J. Immunol. 48, 705\u2013715 (2018).","journal-title":"Eur. J. Immunol."},{"key":"1163_CR62","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3390\/vaccines9091033","volume":"9","author":"MN Uddin","year":"2021","unstructured":"Uddin, M. N. & Roni, M. A. Challenges of storage and stability of mRNA-based COVID-19 vaccines. Vaccines (Basel). 9, 1033 (2021).","journal-title":"Vaccines (Basel)."},{"key":"1163_CR63","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1158\/1078-0432.CCR-23-3940","volume":"30","author":"AM D\u2019Alise","year":"2024","unstructured":"D\u2019Alise, A. M., et al. Phase I trial of viral vector-based personalized vaccination elicits robust neoantigen-specific antitumor T-cell responses. Clin. Cancer Res. 30, 2412\u20132423 (2024).","journal-title":"Clin. Cancer Res."},{"key":"1163_CR64","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler, K., et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823\u2013826 (2016).","journal-title":"Science"},{"key":"1163_CR65","doi-asserted-by":"publisher","first-page":"e01504","DOI":"10.1128\/JCM.01504-17","volume":"56","author":"L Premkumar","year":"2018","unstructured":"Premkumar, L. et al. Development of envelope protein antigens to serologically differentiate Zika virus infection from dengue virus infection. J. Clin. Microbiol. 56, e01504 (2018).","journal-title":"J. Clin. Microbiol."},{"key":"1163_CR66","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41590-018-0210-3","volume":"19","author":"JL Slon Campos","year":"2018","unstructured":"Slon Campos, J. L., Mongkolsapaya, J. & Screaton, G. R. The immune response against flaviviruses. Nat. Immunol. 19, 1189\u20131198 (2018).","journal-title":"Nat. Immunol."},{"key":"1163_CR67","doi-asserted-by":"publisher","first-page":"8384","DOI":"10.1073\/pnas.1704984114","volume":"114","author":"A Balmaseda","year":"2017","unstructured":"Balmaseda, A., et al. Antibody-based assay discriminates Zika virus infection from other flaviviruses. Proc. Natl Acad. Sci. USA 114, 8384\u20138389 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1163_CR68","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0958-1669(99)00003-8","volume":"10","author":"F Baneyx","year":"1999","unstructured":"Baneyx, F. Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol. 10, 411\u2013421 (1999).","journal-title":"Curr. Opin. Biotechnol."},{"key":"1163_CR69","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/nbt1029","volume":"22","author":"F Baneyx","year":"2004","unstructured":"Baneyx, F. & Mujacic, M. Recombinant protein folding and misfolding in Escherichia coli. Nat. Biotechnol. 22, 1399\u20131408 (2004).","journal-title":"Nat. Biotechnol."},{"key":"1163_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13568-019-0926-y","volume":"10","author":"AI Kanno","year":"2020","unstructured":"Kanno, A. I., et al. Optimization and scale-up production of Zika virus \u0394NS1 in Escherichia coli: application of response surface methodology. AMB Express 10, 1\u201313 (2020).","journal-title":"AMB Express"},{"key":"1163_CR71","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1086\/599988","volume":"200","author":"JT Schiller","year":"2009","unstructured":"Schiller, J. T. & Lowy, D. R. Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials. J. Infect. Dis. 200, 166\u2013171 (2009).","journal-title":"J. Infect. Dis."},{"key":"1163_CR72","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","volume":"374","author":"SA Rasmussen","year":"2016","unstructured":"Rasmussen, S. A., Jamieson, D. J., Honein, M. A. & Petersen, M. A. Zika virus and birth defects\u2014reviewing the evidence for causality. N. Engl. J. Med. 374, 1981\u20131987 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1163_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13589-1","volume":"10","author":"C Shan","year":"2019","unstructured":"Shan, C., et al. Maternal vaccination and protective immunity against Zika virus vertical transmission. Nat. Commun. 10, 5677 (2019).","journal-title":"Nat. Commun."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01163-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01163-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01163-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T18:03:10Z","timestamp":1748368990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01163-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1163"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01163-4","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}